The Conference Board Measure of CEO Confidence™ is at its highest level since 2019, marking a significant shift in business sentiment. In this episode of C-Suite Perspectives, Dana Peterson, Chief Economist, joins President and CEO Steve Odland, both of The Conference Board, to discuss the latest results of the Measure of CEO Confidence and the C-Suite Outlook. They discuss why CEOs are positive and whether their concerns, including inflation, cost of debt, and interest rates, track with the economic outlook.
Tune in to find out:
For more Trusted Insights for What’s Ahead®:
C-Suite Perspectives is a series hosted by our President & CEO, Steve Odland. This weekly conversation takes an objective, data-driven look at a range of business topics aimed at executives. Listeners will come away with what The Conference Board does best: Trusted Insights for What’s Ahead®.
C-Suite Perspectives provides unique insights for C-Suite executives on timely topics that matter most to businesses as selected by The Conference Board. If you would like to suggest a guest for the podcast series, please email csuite.perspectives@conference-board.org. Note: As a non-profit organization under 501(c)(3) of the IRS Code, The Conference Board cannot promote or offer marketing opportunities to for-profit entities.
C-Suite Perspectives / 11 Aug 2025
Find out how FIS is staying on the cutting edge of technology while serving clients and communities.
C-Suite Perspectives / 04 Aug 2025
More C-Suite leaders view their boards as effective in 2025, but numerous challenges remain, including keeping up with AI.
C-Suite Perspectives / 29 Jul 2025
We break down the latest data from The Conference Board Consumer Confidence Index®, released today.
C-Suite Perspectives / 28 Jul 2025
Learn how Clorox invested in technological innovation so it could continue delivering superior consumer experiences.
C-Suite Perspectives / 21 Jul 2025
2025 is half over. What issues should human capital leaders focus on during the rest of the year?
C-Suite Perspectives / 14 Jul 2025
Learn why culture and constant innovation are essential to developing life-changing biopharma treatments.